Yahoo Web Search

  1. AZRX: OPTION Trial Readout

    Zacks Small Cap Research via Yahoo FinanceSep 27 12:30 PM

    The coefficient of fat absorption (CFA) was 56% for the MS1819 treatment phase and 86% for the PERT treatment phase. The trial demonstrated a high coefficient of nitrogen absorption (CNA) for ...

  2. ACHV: Post Phase II Investor Day

    Zacks Small Cap Research via Yahoo FinanceSep 25 10:30 AM

    Achieve Life Sciences, Inc. (NASDAQ:ACHV) held its first investor day following the read out of the ORCA-1 trial on September 20, 2019. The event was introduced by CFO John Bencich and included ...

  3. OGEN: Phase 2 Trial of AG013 More Than 2/3rd Enrolled…

    Zacks Small Cap Research via Yahoo FinanceOct 02 12:15 PM

    The Phase 2 trial (NCT03234465) is expected to enroll approximately 200 subjects with head and neck cancer receiving chemotherapy and radiation who will receive either AG013 (2.0 x 1011 CFU) ...

  4. MDNA.TO: Increased Overall Survival in rGBM Patients Seen with High Dose MDNA55…

    Zacks Small Cap Research via Yahoo FinanceSep 30 10:45 AM

    The Phase 2b clinical trial enrolled a total of 46 rGBM patients experiencing their first or second GBM relapse (NCT02858895). It is a multi-center, open label, single arm study with the primary ...

  5. U.S. Brings First Fiat Diesel Charges, Indicting Engineer

    Bloomberg via Yahoo FinanceSep 24 23:01 PM

    In an indictment unsealed Tuesday in Michigan, Emanuele Palma, a senior Fiat Chrysler engineer, was accused of conspiring with others at the company to mislead regulators and the public about ...

  6. Daimler said on Tuesday Mercedes-Benz customers in Germany could apply for a 3,000 euro ($3,350) subsidy to upgrade the exhaust filters of older, polluting diesel vehicles, the latest effort ...

  7. VVUS: Debt Reduced by ~$50 Million

    Zacks Small Cap Research via Yahoo FinanceOct 07 17:45 PM

    Vivus has held substantial cash on its balance sheet and now that they are close to operating free cash flow breakeven, holding additional cash reserves is not warranted. Below we provide the ...

  8. CFRX: Planning to Initiate Phase 3 Superiority Trial for Exebacase in 4Q19...

    Zacks Small Cap Research via Yahoo FinanceOct 07 13:05 PM

    On October 2, 2019, ContraFect Corp. (NASDAQ:CFRX) announced that following a successful ‘end-of-Phase 2’ meeting with the FDA the company is planning to conduct a single Phase 3 clinical trial ...

  9. Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.

    Globenewswire Test via Yahoo FinanceOct 04 12:04 PM

    Copies of the new Zacks SCR report can be obtained via the following link:PBIO: Groundwork laid; opportunities abound Any opinions, judgments, estimates, or forecasts regarding the...

  10. By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio Innovations, Inc. (NASDAQ:MBII) has received approval for the use of Stargus in Mexico. This joins Grandevo ...

  1. Ads
    related to SCR